...
首页> 外文期刊>Progress in Health Sciences >Matrix metalloproteinases in urinary system tumours. Part I - Matrix metalloproteinases in renal cell carcinoma
【24h】

Matrix metalloproteinases in urinary system tumours. Part I - Matrix metalloproteinases in renal cell carcinoma

机译:泌尿系统肿瘤中的基质金属蛋白酶。第一部分-肾细胞癌中的基质金属蛋白酶

获取原文
           

摘要

Extracellular matrix metalloproteinases - MMPs, also referred to as matrixines, provide a group of proteolytic enzymes. They belong to the family of endopeptidases that break down elements of extracellular matrix, resulting in its continuous remodelling. Their activity is regulated at multiple levels, while tissue inhibitors of metalloproteinases play a major role in this process. Metalloproteinases play a significant part in neoplastic processes due to their contribution to local tumour invasion and formation of distant metastases, as well as to angiogenesis.Urinary tract tumours pose a significant diagnostic and therapeutic challenge and their incidence tends to grow every year. The aim of this part of review is to describe extracellular matrix and matrix metalloproteinases and to highlight the contribution of matrix metalloproteinases in the development of renal clear cell carcinoma.
机译:细胞外基质金属蛋白酶-MMP,也称为基质素,提供一组蛋白水解酶。它们属于内肽酶家族,其破坏细胞外基质的元素,导致其连续重塑。它们的活性在多个水平上受到调节,而金属蛋白酶的组织抑制剂在该过程中起主要作用。金属蛋白酶在肿瘤形成过程中起着重要的作用,因为它们对局部肿瘤的侵袭和远处转移的形成以及对血管生成的贡献。泌尿道肿瘤提出了重大的诊断和治疗挑战,其发病率每年都在增长。本部分综述的目的是描述细胞外基质和基质金属蛋白酶,并强调基质金属蛋白酶在肾透明细胞癌发展中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号